FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120316780> ?p ?o ?g. }

• W3120316780 endingPage "3176" @default.
• W3120316780 startingPage "3162" @default.
• W3120316780 abstract "To evaluate feasibility of intradermal (i.d.) adalimumab administration using hollow microneedles, and to compare a single i.d. dose of adalimumab using a hollow microneedle with a single subcutaneous (s.c.) dose using a conventional needle.In this single-centre double-blind, placebo-controlled, double-dummy clinical trial in 24 healthy adults we compared 40 mg adalimumab (0.4 mL) administered i.d. using a hollow microneedle with a s.c. dose using a conventional needle. Primary parameters were pain, acceptability and local tolerability; secondary parameters safety, pharmacokinetics and immunogenicity. We explored usability of optical coherence tomography, clinical photography, thermal imaging, and laser speckle contrast imaging to evaluate skin reaction after i.d. injections. In vitro protein analysis was performed to assess compatibility of adalimumab with the hollow microneedle device.While feasible and safe, injection pain of i.d. adalimumab was higher compared to s.c. adalimumab (35.4 vs. 7.9 on a 100-point visual analogue scale). Initial absorption rate and relative bioavailability were higher after i.d. adalimumab (time to maximum plasma concentration = 95 h [47-120]; Frel = 129% [6.46%]) compared to s.c. adalimumab (time to maximum plasma concentration = 120 h [96-221]). Anti-adalimumab antibodies were detected in 50% and 83% of the subjects after i.d. and s.c. adalimumab, respectively. We observed statistically significantly more erythema and skin perfusion after i.d. adalimumab, compared to s.c. adalimumab and placebo injections (P < .0001). Cytokine secretion after whole blood lipopolysaccharide challenge was comparable between administration routes.Intradermal injection of adalimumab using hollowing microneedles was perceived as more painful and less accepted than s.c. administration, but yields a higher relative bioavailability with similar safety and pharmacodynamic effects." @default.
• W3120316780 created "2021-01-18" @default.
• W3120316780 creator A5006485310 @default.
• W3120316780 creator A5010012249 @default.
• W3120316780 creator A5018797798 @default.
• W3120316780 creator A5019110317 @default.
• W3120316780 creator A5021841624 @default.
• W3120316780 creator A5024633266 @default.
• W3120316780 creator A5029733252 @default.
• W3120316780 creator A5031708632 @default.
• W3120316780 creator A5050087953 @default.
• W3120316780 creator A5055609072 @default.
• W3120316780 creator A5056385498 @default.
• W3120316780 creator A5058166328 @default.
• W3120316780 creator A5058668741 @default.
• W3120316780 creator A5059395956 @default.
• W3120316780 creator A5072790675 @default.
• W3120316780 creator A5073070631 @default.
• W3120316780 creator A5075773989 @default.
• W3120316780 creator A5079265856 @default.
• W3120316780 creator A5081334313 @default.
• W3120316780 creator A5083164288 @default.
• W3120316780 creator A5083688526 @default.
• W3120316780 creator A5086868801 @default.
• W3120316780 date "2021-02-02" @default.
• W3120316780 modified "2023-10-15" @default.
• W3120316780 title "Comprehensive evaluation of microneedle‐based intradermal adalimumab delivery <i>vs</i> . subcutaneous administration: results of a randomized controlled clinical trial" @default.
• W3120316780 cites W1520935728 @default.
• W3120316780 cites W1523116602 @default.
• W3120316780 cites W1586699825 @default.
• W3120316780 cites W1963839023 @default.
• W3120316780 cites W1965479467 @default.
• W3120316780 cites W1973820350 @default.
• W3120316780 cites W1978261191 @default.
• W3120316780 cites W1989291415 @default.
• W3120316780 cites W1999658183 @default.
• W3120316780 cites W2006975935 @default.
• W3120316780 cites W2007539416 @default.
• W3120316780 cites W2008927880 @default.
• W3120316780 cites W2011316052 @default.
• W3120316780 cites W2017534125 @default.
• W3120316780 cites W2030097980 @default.
• W3120316780 cites W2048049691 @default.
• W3120316780 cites W2049340318 @default.
• W3120316780 cites W2051129711 @default.
• W3120316780 cites W2065303540 @default.
• W3120316780 cites W2070610775 @default.
• W3120316780 cites W2101089137 @default.
• W3120316780 cites W2101338500 @default.
• W3120316780 cites W2115722908 @default.
• W3120316780 cites W2118873626 @default.
• W3120316780 cites W2119046820 @default.
• W3120316780 cites W2147802232 @default.
• W3120316780 cites W2149065814 @default.
• W3120316780 cites W2149174813 @default.
• W3120316780 cites W2150944237 @default.
• W3120316780 cites W2163972237 @default.
• W3120316780 cites W2409984077 @default.
• W3120316780 cites W2472898584 @default.
• W3120316780 cites W2475096707 @default.
• W3120316780 cites W2510731647 @default.
• W3120316780 cites W2557320445 @default.
• W3120316780 cites W25898841 @default.
• W3120316780 cites W2593045032 @default.
• W3120316780 cites W2791601614 @default.
• W3120316780 cites W2793035480 @default.
• W3120316780 cites W2900677864 @default.
• W3120316780 cites W2901552928 @default.
• W3120316780 cites W2977374807 @default.
• W3120316780 doi "https://doi.org/10.1111/bcp.14729" @default.
• W3120316780 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8359405" @default.
• W3120316780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33403697" @default.
• W3120316780 hasPublicationYear "2021" @default.
• W3120316780 type Work @default.
• W3120316780 sameAs 3120316780 @default.
• W3120316780 citedByCount "6" @default.
• W3120316780 countsByYear W31203167802022 @default.
• W3120316780 countsByYear W31203167802023 @default.
• W3120316780 crossrefType "journal-article" @default.
• W3120316780 hasAuthorship W3120316780A5006485310 @default.
• W3120316780 hasAuthorship W3120316780A5010012249 @default.
• W3120316780 hasAuthorship W3120316780A5018797798 @default.
• W3120316780 hasAuthorship W3120316780A5019110317 @default.
• W3120316780 hasAuthorship W3120316780A5021841624 @default.
• W3120316780 hasAuthorship W3120316780A5024633266 @default.
• W3120316780 hasAuthorship W3120316780A5029733252 @default.
• W3120316780 hasAuthorship W3120316780A5031708632 @default.
• W3120316780 hasAuthorship W3120316780A5050087953 @default.
• W3120316780 hasAuthorship W3120316780A5055609072 @default.
• W3120316780 hasAuthorship W3120316780A5056385498 @default.
• W3120316780 hasAuthorship W3120316780A5058166328 @default.
• W3120316780 hasAuthorship W3120316780A5058668741 @default.
• W3120316780 hasAuthorship W3120316780A5059395956 @default.
• W3120316780 hasAuthorship W3120316780A5072790675 @default.
• W3120316780 hasAuthorship W3120316780A5073070631 @default.
• W3120316780 hasAuthorship W3120316780A5075773989 @default.
• W3120316780 hasAuthorship W3120316780A5079265856 @default.
• W3120316780 hasAuthorship W3120316780A5081334313 @default.

• next